Rockefeller Capital Management’s Bionano Genomics BNGO Stock Holding History

Rockefeller Capital Management’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1	Buy	+1	New	+$1	﹤0.01%	4726
2023 Q1	–	Sell	-10	Closed	-$8K	–	2207
2022 Q4	$8K	Buy	10 +3	+43%	+$3.77K	﹤0.01%	3161
2022 Q3	$7K	Buy	+7	New	+$9.25K	﹤0.01%	3216
2022 Q2	–	Sell	-1	Closed	-$1K	–	4103
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	3702
2021 Q4	$2K	Hold	1	–	–	﹤0.01%	3514
2021 Q3	$3K	Buy	+1	New	+$3.5K	﹤0.01%	3315
2021 Q2	–	Sell	-1	Closed	-$3K	–	3438
2021 Q1	$3K	Buy	+1	New	+$5.64K	﹤0.01%	3003

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Rockefeller Capital Management's BNGO Position: Q2 2026 in Review

Rockefeller Capital Management opened a new position in Bionano Genomics (BNGO) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #4726 among its holdings. This is a return to the name: Rockefeller Capital Management previously reported a position in BNGO as recently as Q4 2022.

Rockefeller Capital Management first reported a position in BNGO in Q1 2021 and has held it in 7 quarters since. The position peaked at $8K in Q4 2022. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Rockefeller Capital Management held 1 share of Bionano Genomics worth $1 as of Q2 2026.
Bionano Genomics was a new Rockefeller Capital Management position in Q2 2026.
Bionano Genomics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4726 holding.
Rockefeller Capital Management first reported a position in Bionano Genomics in Q1 2021 and has held it in 7 quarters since.
Rockefeller Capital Management's Bionano Genomics position peaked at $8K in Q4 2022.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.